Dedifferentiation in prostate cancer

Case submitted by Nazim Coskun

68-year-old male

Prostate adenocarcinoma

Gleason 5+4

Loading

{{ parseInt(imageIndex) + 1 }} / {{ scans[scanIndex]?.series[seriesIndex]?.images?.length }}
{{ marker.note }}

  • Selected slices showing increased PSMA expression in multiple bone metastases.
  • Multiple hypodense lesions in liver did not show PSMA expression.

Patient underwent 18F-FDG PET/CT and 68Ga-DOTA-TATE PET/CT for the characterization of liver lesions.

Loading

{{ parseInt(imageIndex) + 1 }} / {{ scans[scanIndex]?.series[seriesIndex]?.images?.length }}
{{ marker.note }}

Multiple liver lesions did not demonstrate 68Ga-DOTA-TATE uptake.

Loading

{{ parseInt(imageIndex) + 1 }} / {{ scans[scanIndex]?.series[seriesIndex]?.images?.length }}
{{ marker.note }}

Selected slices showing increased 18F-FDG uptake in liver metastases.

Case Notes

Liver metastases in prostate cancer are usually associated with dedifferentiation and high-grade cancers, leading to loss of PSMA expression .

Updated on Aug 24, 2024